Article Information
History
- December 20, 2016.
Article Versions
- Version 1 (December 2, 2016 - 15:22).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Michiel van Veen1+,
- Elisa Matas-Rico1+,
- Koen van de Wetering25,
- Daniela Leyton-Puig1,
- Katarzyna M. Kedziora16,
- Nicolai Sidenius4,
- Kees Jalink1,
- Anastassis Perrakis3 and
- Wouter H. Moolenaar1,*
- 1Division of Cell Biology, The Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam, The Netherlands
- 2Division of Molecular Oncology, The Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam, The Netherlands
- 3Division of Biochemistry, The Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam, The Netherlands
- 4IFOM, The FIRC Institute of Molecular Oncology, Milan, Italy
- ↵*Corresponding author; E-mail: w.moolenaar{at}nki.nl
↵+ Equal first authorship